In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos.
The response of microtubules to treatment with vinca alkaloids was investigated in vivo and in situ in the embryonic nervous system of mice. For this purpose we used rotatory cultures of post-implanted embryos in a serum medium containing the alkaloid combined with immunofluorescence using a tubulin-specific polyclonal antibody on high molecular weight polyethylene glycol embedded semithin sections. In mitotic cells, kinetochore microtubules were seen to be more resistant to the action of vinca alkaloids than interpolar microtubules. Increasing drug concentrations induced an increasing rate of mitosis together with an increasing rate of disassembly of the cytoplasmic microtubule complex, suggesting a probable relation between these events. In bipolar neuroepithelial cells at interphase, a small pool of microtubules was resistant to the vinca alkaloids. These microtubules were located near the centriolar apparatus associated with the primary cilium; they were short, curly and bent. Disruption of the cytoplasmic microtubule complex did not alter the shape of the bipolar neuroepithelial cells. In the axonal profiles, a drug-stable pool of microtubules were not disrupted by the alkaloids and were also short. They seem to act as microtubule organizing centres. These observations suggest vinca alkaloids seem to act in vivo much more by inducing, at a given concentration, the disruption of a particular group of microtubules without altering the others. The fact that these drugs affect the number, but not the length, of the microtubules raises the hypothesis that these drugs act on microtubules by a mechanism similar to that described as "dynamic instability".
Meininger
V
V
Laboratoire d'Anatomie, UER Biomédicales des St-Pères et Broussais-Hôtel-Dieu, Paris, France.
Binet
S
S
Chaineau
E
E
Fellous
A
A
D000818:Animals; D001369:Axons / Q000648:ultrastructure; D004622:Embryo, Mammalian / Q000187:drug effects; D005455:Fluorescent Antibody Technique; D066298:In Vitro Techniques; D051379:Mice; D008854:Microscopy, Electron; D008870:Microtubules / Q000187:drug effects* / Q000648:ultrastructure; D008938:Mitosis; D009420:Nervous System / Q000187:drug effects / Q000196:embryology / Q000648:ultrastructure; D009474:Neurons / Q000648:ultrastructure; D014404:Tubulin / Q000032:analysis; D014747:Vinblastine / Q000031:analogs & derivatives / Q000494:pharmacology; D014748:Vinca Alkaloids / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology; D000077235:Vinorelbine
D014404:Tubulin; D014748:Vinca Alkaloids; D014750:Vincristine; D014747:Vinblastine; D000077235:Vinorelbine